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Background: Rapid diagnostic tests (RDTs) are now widely used for laboratory confirmation of suspected malaria
cases to comply with the World Health Organization recommendation for universal testing before treatment.
However, many malaria programmes lack quality control (QC) processes to assess RDT use under field conditions.
Prior research showed the feasibility of using the dried tube specimen (DTS) method for preserving Plasmodium
falciparum parasites for use as QC samples for RDTs. This study focused on the use of DTS for RDT QC and
proficiency testing under field conditions.
Methods: DTS were prepared using cultured P. falciparum at densities of 500 and 1,000 parasites/μL; 50 μL aliquots
of these along with parasite negative human blood controls (0 parasites/μL) were air-dried in specimen tubes and
reactivity verified after rehydration. The DTS were used in a field study in the Oromia Region of Ethiopia. Replicate
DTS samples containing 0, 500 and 1,000 parasites/μL were stored at 4°C at a reference laboratory and at ambient
temperatures at two nearby health facilities. At weeks 0, 4, 8, 12, 16, 20, and 24, the DTS were rehydrated and tested
on RDTs stored under manufacturer-recommended temperatures at the RL and on RDTs stored under site-specific
conditions at the two health facilities. Reactivity of DTS stored at 4°C at the reference laboratory on RDTs stored at the
reference laboratory was considered the gold standard for assessing DTS stability. A proficiency-testing panel consisting
of one negative and three positive samples, monitored with a checklist was administered at weeks 12 and 24.
Results: At all the seven time points, DTS stored at both the reference laboratory and health facility were reactive on
RDTs stored under the recommended temperature and under field conditions, and the DTS without malaria parasites
were negative. At the reference laboratory and one health facility, a 500 parasites/μL DTS from the proficiency panel
was falsely reported as negative at week 24 due to errors in interpreting faint test lines.
Conclusions: The DTS method can be used under field conditions to supplement other RDT QC methods and health
worker proficiency in Ethiopia and possibly other malaria-endemic countries.
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Malaria continues to be a major cause of morbidity and
mortality worldwide; over 40% of the world’s population,
more than 3.3 billion people, live in countries with on-
going transmission and remain at risk [1]. In the 2013
World Malaria Report, it was estimated that in 2012* Correspondence: maidoo@cdc.gov
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deaths, of which 90% occurred in sub-Saharan Africa [2].
Accurate diagnosis and treatment of malaria is critical
in preventing severe manifestations and mortality of the
disease and for disease control. The World Health
Organization (WHO) revised malaria treatment guide-
lines in 2010, emphasizing the accurate parasitological
confirmation of any suspected malaria fever case before
prompt anti-malarial drug administration [3]. The revised
WHO recommendation was aimed at decreasing the num-
ber of inappropriate prescriptions of anti-malarial drugs in. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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mote the appropriate treatment of patients presenting with
febrile diseases of other aetiology. Critical to this revised
policy is the availability of quality-assured confirmatory
malaria diagnostic tests to guide malaria treatments.
Based on its performance characteristics, ease of use
by non-laboratory staff working in health posts without
laboratory facilities and in communities, rapid diagnostic
tests (RDTs) have become a useful alternative to micro-
scopic examination of thick blood films [4-9] for detec-
tion of infection, although thin film microscopy is still
required for species identification when appropriate.
Malaria RDTs can perform to a level similar to that pro-
vided by high-quality thick blood smear microscopy, can
be introduced into peripheral health facilities and also
be effectively used by community health workers [10-13]
in remote rural locations that lack laboratory capacity
for microscopy. The introduction of malaria RDT can
also be useful in encouraging the rational use of expen-
sive and sometimes limited availability of anti-malarial
drugs [14-16].
Despite their utility, concerns about inter- and intra-
lot variation of malaria RDTs and their susceptibility to
high temperatures and humidity [17] require that RDT
introduction is accompanied by a robust quality assur-
ance/quality control (QA/QC) system to monitor test per-
formance. Currently, the WHO, in collaboration with the
US Centers for Disease Control and Prevention and the
Foundation for Innovative New Diagnostics, conducts an-
nual malaria RDT evaluations that monitor manufacturing
quality of many of the widely used RDT products [17]. In
addition to the product evaluation, WHO/FIND provides
a free, pre-procurement, lot-testing service for countries
that purchase RDTs; this service is routinely utilized by
donors, including the Global Fund to Fight HIV/AIDS,
Tuberculosis and Malaria and the US President’s Malaria
Initiative. The product evaluation and pre-procurement
lot-testing provide a quality system for RDTs prior to the
tests being deployed in the field.
The RDTs distributed in many malaria-endemic coun-
tries may be exposed to higher temperatures than
recommended by manufacturers [18]; in Ethiopia, the
maintenance of a logistical supply chain with relatively
cool ambient conditions may be especially difficult since
items might be stored for days or weeks within shipping
containers, and many items are imported through the
port of Djibouti where very high temperatures are preva-
lent. A major challenge to widespread RDT use in the
field is the ability to monitor their continued perform-
ance after exposure to the high temperature conditions
typical of many malaria-endemic countries. In Ethiopia,
a WHO/FIND certified malaria RDT testing laboratory
is available at the Ethiopian Public Health Institute in
Addis Ababa, but malaria infections are infrequentlyreported in Addis Ababa, and standardized reagents for
quality control of RDTs have been unavailable previously.
The three current methods for monitoring RDT per-
formance in the field include making blood smear mi-
croscopy slides in parallel with a subset of RDTs [12,19],
directly observing malaria RDTs being performed and
asking health workers to interpret pictorial representa-
tions of test results. These last two methods only assure
the correct performance and interpretation of the test by
the health worker and not the performance characteristics
(sensitivity, specificity, positive, and negative predictive
values) and accuracy of the RDT test over time. Preparing
and examining blood smear slides depends on the avail-
ability of capacity for good quality microscopy and places
additional burden on QA/QC for malaria microscopy.
However, the major drawback to using smear microscopy
to QC RDTs is that microscopy detects intact parasites
while RDTs detect circulating parasite antigens. The para-
site antigens detected by most malaria RDTs, histidine
rich protein 2 (HRP2) and to a lesser extent plasmodium
lactate dehydrogenase (pLDH) are known to persist for
several days after parasite clearance and therefore limit
the usefulness of microscopy for RDT QC [20]. Currently,
no easily implementable method for RDT QC exists at
central reference laboratories or in rural health facilities
and such methods are needed to support quality universal
diagnosis of malaria in remote locations.
RDTs are primarily designed for use on fresh capillary
whole blood. Therefore, the QC sample needs to be a
standardized, fresh and well-characterized clinical speci-
men, but significant challenges exist associated with
sample variability and preservation [21]. Efforts at devel-
oping suitable recombinant antigens for QC testing [22]
have so far been unrealized.
A method for RDT QC using dried Plasmodium fal-
ciparum infected blood samples in tubes has been re-
ported [23]. These dried tube specimens (DTS) had stable
RDT reactivity for over 52 weeks in the laboratory when
stored under refrigeration (4°C) conditions, but needed to
be further tested under field conditions. Factors that may
influence the practicability of assembling DTS into a
proficiency-testing panel to determine health workers’
ability to use and interpret RDT results were also assessed.
Methods
The DTS were prepared as described [23]. Briefly,
culture-grown P. falciparum parasites (strain 3D7) were
diluted using haematocrit-matched parasite negative blood
(0 parasites/μL) washed in RPMI1640 culture medium (Life
Technologies, Grand Island, NY, USA) to concentrations of
500 or 1,000 parasites/μL. After testing for reactivity on
replicate RDTs, 50 μL aliquots of each dilution (0, 500 and
1,000 parasites/μL) were transferred into open skirted base,
conical-bottomed Sarstedt® Type I micro tubes (Sarstedt
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To test for retention of reactivity after drying, one tube
each of 0, 500 and 1,000 parasites/μL DTS was rehydrated
in PBS-Tween solution as previously described [23] and
tested on the same RDT brand as that used prior to dry-
ing. After verifying baseline RDT reactivity, the DTS were
capped and stored in a 4°C refrigerator until transported
to Addis Ababa, Ethiopia in November 2012.
Study setting (site selection)
The regional reference laboratory, Adama Regional Refer-
ence Laboratory (ARRL), about 110 km southeast of Addis
Ababa within the Oromia Regional State, was selected as
the reference laboratory due to the availability of controlled
temperature environments to store DTS at the recom-
mended 4°C. The criteria for choosing the two peripheral
health centres were the routine use of RDTs and the feasi-
bility of RDT storage at ambient temperature. To simplify
study logistics, the two health centres were selected in
order for both to be visited on the same day and within
eight hours of DTS reconstitution at the reference labora-
tory. Accordingly, Wanji Health Centre, located 10 km and
Walanchiti Health Centre, located 27 km from ARRL and
within the Great Rift Valley in the central part of Ethiopia
were selected as the health centres for this study.
RDT selection
The malaria RDT brand chosen for the study was the
CareStart malaria pLDH/HRP2 combo test. These RDTs,
with an expiry date of February 2015, were obtained from
a recent shipment to the UNICEF central warehouse in
Addis Ababa procured through the PMI and meant for
distribution throughout Ethiopia. The CareStart malaria
pLDH/HRP2 combo test contains a membrane strip pre-
coated with two monoclonal antibodies, designed for the
diagnosis of P. falciparum and/or other Plasmodium spe-
cies, including Plasmodium vivax.
DTS accession and field monitoring
DTS were prepared at CDC, Atlanta in advance, with al-
iquots of 0 parasites (negative), 500 and 1,000 parasites/
μL and shipped on ice packs to Ethiopia. Because DTS
were initially tested at baseline in Atlanta with different
RDT brands from those used in Ethiopia, RDT reactivity
was confirmed on the CareStart malaria pLDH/HRP2
combo RDT brand immediately upon arrival in Ethiopia.
Following confirmation of reactivity, DTS were stored at
4°C at ARRL and under site-specific conditions at the
two health centres. The CareStart Combo RDTs from
the same lot as mentioned above were also distributed
to these three study sites. According to the product insert
supplied by the manufacturer, the CareStart Combo RDT
has sensitivity and specificity for P. falciparum of 98 and
97.5%, respectively. However, the parasite density of thesamples used in defining these test characteristics and the
lower limit of detection of the test were not provided.
At time week zero and at four-week intervals over a
period of six months, RDTs stored at ARRL under
manufacturer-recommended storage conditions and the
same lot/batch of RDTs stored at room temperature in the
two health centres were tested for performance using DTS
stored at 4°C at the ARRL and at room temperature in the
peripheral health centres. DTS were rehydrated with the
same volume of PBS/Tween 20 solution as initial blood vol-
ume and tested on RDTs within eight hours of rehydration.
DTS field monitoring
Adama regional reference laboratory (ARRL) testing
On the day of testing, one aliquot each of DTS at 0, 500
and 1,000 parasites/μL stored at 4°C at the ARRL was
rehydrated over one hour with two drops of PBS/Tween
using a plastic Pasteur pipette (i.e., approximately 50 μL)
and tested on duplicate RDTs stored under manufacturer-
recommended storage conditions (≤30°C) at the reference
laboratory. Field testing at the health centres was done on
the same day. The ARRL site served as the gold standard
for DTS and RDT optimal storage conditions and RDT
test performance in Ethiopia while the two health centres
represented peripheral facility level ambient conditions for
comparison.
Field-testing
On the same day as ARRL testing, the rehydrated DTS
and RDTs from ARRL were transported at ~4°C and
manufacturer-recommended storage conditions (i.e., opti-
mal conditions), respectively, to the first health centre. At
the health centre, rehydrated DTS from ARRL and rehy-
drated replicate health centre-stored (room temperature)
DTS were each tested on both RDTs brought from
ARRL and health centre-stored RDTs. For the purposes
of this evaluation, DTS were tested within eight hours
of rehydration.
Quality control
To avoid errors that could be attributed to the compe-
tence of health-worker performance and interpretation of
RDT results, regional laboratory staff with experience in
performing malaria RDTs were selected and provided with
additional training. To rule out interpersonal variability,
the same person was appointed for the whole study
period. In each month the collected data were checked by
the investigators for any transcriptional error resulting ei-
ther while interpreting or summarizing the data from the
facility reports.
Proficiency-testing panel
Four DTS tubes stored at 4°C at ARRL were assembled
into blinded panels each consisting of one 0 parasites/μL
Tamiru et al. Malaria Journal  (2015) 14:11 Page 4 of 8(negative control), two 500 parasites/μL and one 1,000
parasites/μL DTS tubes for PT. During health centre visits
at weeks 12 and 24, health workers at the facility were
asked to perform RDT tests using this panel on RDTs
stored under manufacturer-suggested conditions brought
from ARRL. Using a checklist and without intervention,
ARRL staff observed and scored performance of nine crit-
ical steps in RDT testing and result interpretation by health
centre staff. Errors in test performance by health centre
staff were corrected by ARRL staff after the proficiency-
testing was completed.
Data collection procedures and management
The testing site name, week and test results of the three
study sites were collected on a standard form every four
weeks and then transferred to a single form. Proficiency
panel test results were recorded on a separate form. The
results were subsequently transferred into an electronic
database, Microsoft Excel.
Data analysis
The results obtained from ARRL were considered the
gold standard by which to assess the DTS and RDT stored
under field conditions in the two health centres. The con-
cordance of ARRL results with the result from health
centre-DTS tested on ARRL RDT was used to show the
stability of health centre-stored DTS. The concordance of
results of ARRL-stored DTS on the health centre-stored
RDTs with ARRL-stored DTS on ARRL-stored RDTs de-
termined the stability of health centre-stored RDTs.
Ethical clearance
The protocol for this study was reviewed and approved
by the Human Subjects Coordinators for the Division of
Parasitic Diseases and Malaria and the Center for Global
Health, Centers for Disease Control and Prevention,
Atlanta. A full Institutional Review Board assessment
was not required because no human or animal subjects




At ARRL where both DTS and RDT were stored at the
recommended temperatures, the DTS (at 0, 500 and
1,000 parasites/μL) retained their reactivity at all the seven
testing time points for 24 weeks (Table 1). The expected
results were obtained for four replicates of each para-
site concentration of DTS at every time point (a total of
84 tests).
Health facility testing
At both health centres the peripheral health centre-
stored DTS at P. falciparum parasite concentrations of0, 500 and 1,000 parasites/μL produced the expected re-
sults at all the seven time points (a total of 21 tests/facility)
when tested on RDT transferred from ARRL (Table 2).
Similar to the ARRL results, when tested on health centre-
stored RDTs, the reconstituted DTS, the same samples as
the three concentrations used at ARRL, were negative for
0 parasites/μL and positive for 500 and 1,000 parasites/μL
at all time points (Table 2).
Health centre-stored DTS were also tested on health
centre-stored RDTs. This health centre-specific testing
was meant to demonstrate the stability of DTS under
field specific storage conditions and their utility as QC
samples for RDTs stored under the same conditions. In
this testing, DTS at 0, 500 and 1,000 parasites/μL stored
at room temperature in Walanchiti Health Centre and
Wanji Gefersa Health Centre retained their reactivity on
RDTs stored under the same conditions at all the time
points from week 0 to week 24. Overall 21 tests per facility
using DTS samples from each concentration retained their
baseline reactivity (Table 2).
Proficiency-panel testing
Proficiency-panel testing results indicated that of the
three study sites, only at Wanji Gefersa Health Centre
were all samples in the panel scored correctly at the two
panel testing points, week 12 and week 24. The other
two study sites, ARRL and Walanchiti Health Centre re-
ported false results for panel samples at 500 parasites/μL
on week 24. At ARRL three out of four faint bands were
reported as negative and at Walanchiti Health Centre,
two of four faint bands were reported as negative at week
24. In total, 16 tests, four each of the four panel samples,
were tested at each site at week 12 and week 24. There-
fore, 16/16 panel samples at Wanji Gefersa Health Centre,
13/16 at ARRL and 14/16 at Walanchiti Health Centre
were reported correctly at week 24 (Table 3).
While performing the DTS proficiency-testing panel,
study site staff were assessed for procedural mistakes
using a nine-step checklist (Table 4) completed by observ-
ing the technicians. The assessment showed that at week
12 one technician added excess blood than the test instruc-
tion specified. At week 24, technicians from Walanchiti
Health Centre (same technician from week 12) and ARRL
interpreted a faint positive band incorrectly as a ‘no band’
(Table 4) and scored the test as negative.
Discussion
Malaria RDTs are increasingly being used in most mal-
arious countries in sub-Saharan Africa and are now
distributed to peripheral health facilities including rural
health posts, and to health centres without laboratories
and sometimes to volunteers working in communities
with minimal training. In these peripheral settings, it may
be difficult to transport and to maintain RDTs within





Wk0 Wk4 Wk8 Wk12 Wk16 Wk20 Wk24
0 P/μL − − − − − − − − − − − − − − − − − − − − − − − − − − − −
500 P/μL + + + + + + + + + + + + + + + + + + + + + + + + + + + +
1,000 P/μL + + + + + + + + + + + + + + + + + + + + + + + + + + + +
− = Negative test result, + = positive test result.
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practical way of limiting the exposure of RDTs to high
temperatures is to limit prolonged storage under extreme
conditions, and to maintain a ‘cool’ supply chain, but it is
often impractical or extremely difficult to determine that
RDTs were never exposed to extreme environmental con-
ditions at some time after manufacture. Previously, quality
control of RDTs comprised simultaneous preparation of
smear slides for microscopy along with a proportion of
rapid tests. However, the methodology has several prac-
tical limitations and has largely been abandoned since
RDTs detect parasite antigens as opposed to actual para-
sites by microscopy. Currently, the only viable, easily
implementable methodology is to directly observe the use
of RDTs at the facility during supervision and through
health worker interpretation of photographs of RDT re-
sults. None of the methods mentioned above adequately
determine reduction in RDT performance resulting from
exposure to excessive temperature and humidity typical of
malaria-endemic areas or other adverse conditions. The
lack of an appropriate quality control method for RDT,
especially the absence of positive control samples, might
also undermine confidence in the accuracy of malaria
RDT results by health workers [24,25]. Therefore, a prac-
tical method for malaria RDT QC on an ongoing basis re-
mains critical to the widespread use of malaria RDTs in
remote rural areas.
The potential for using dried culture-derived P.
falciparum-infected blood as QC samples to identify fail-








0 500 1,000 0 500 1,000 0 500 1
ARRL Walanchiti HC - + + - + + - + +
Walanchiti HC ARRL - + + - + + - + +
Walanchiti HC Walanchiti HC - + + - + + - + +
ARRL Wanji HC - + + - + + - + +
Wanji HC ARRL - + + - + + - + +
Wanji HC Wanji HC - + + - + + - + +
− = Negative test result, + = positive test result, HC = health centre.Also, additional experiments indicated that DTS at 1,000
and 2,000 parasites/μL and stored at 4°C were stable for
up to two years ([23] and Additional file 1).
In the experiments described here, DTS stored under
refrigeration in a reference laboratory and those stored
at ambient temperatures under field conditions were
stable for the seven-month duration of the study, repeat-
edly providing expected results. Storage temperatures in
the health centres were not measured to determine
whether there was significant temperature differences
between the health centre- and the reference laboratory-
stored DTS. In addition, ambient temperatures, although
much higher than 4°C during that period in Ethiopia,
were likely within manufacturer-recommended storage
temperatures (4°C-30°C) according to weather data from
the Ethiopian Meteorology Agency. Despite the potential
differences in storage temperatures between the health
centres and reference laboratory, there is no reason to
believe they had any measurable effect on RDT perform-
ance. Ensuring that RDTs perform as expected is a major
reason to have a QC method. Therefore, one of the uses
of P. falciparum DTS as a standardized substrate for
RDT testing is to assure health workers of the continued
reliability of the RDT test results at their facility. The
availability of QC data regarding RDTs could result in
trust of RDT results and therefore fewer instances of
over-treatment. In addition to QC testing, DTS were
assessed for utility as proficiency-testing samples for
health workers. Proficiency-testing is an important com-
ponent of QA and having well-characterized samples forth centre and ARRL-stored RDTs
Wk12 Wk16 Wk20 Wk24
μL Parasites/μL Parasites/μL Parasites/μL Parasites/μL
,000 0 500 1,000 0 500 1,000 0 500 1,000 0 500 1,000
- + + - + + - + + - + +
- + + - + + - + + - + +
- + + - + + - + + - + +
- + + - + + - + + - + +
- + + - + + - + + - + +
- + + - + + - + + - + +
Table 3 Proficiency testing results of the ARRL, Wanji health centre and Walanchiti health centre
Study site PT sample Code PT result Remark/comment
Week 12 Week 24
ARRL Four 1,000 p/μL 001 + + + + + + + +
Four 500 p/μL 002 + + + + + + + +
Four 0 p/μL 003 − − − − − − − −
Four 500 p/μL 004 + + + + +− − − Faint test line missed
Wanji Health Centre Four 1,000 p/μL 001 + + + + + + + +
Four 500 p/μL 002 + + + + + + + +
Four 0 p/μL 003 − − − − − − − −
Four 500 p/μL 004 + + + + + + + +
Walanchiti Health Centre Four 1,000 p/μL 001 + + + + + + + +
Four 500 p/μL 002 + + + + + + − − Faint test line missed
Four 0 p/μL 003 − − − − − − − −
Four 500 p/μL 004 + + + + + + + +
− = Negative test result, + = positive test result.
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that RDT testing as practiced by health workers in
rural areas is providing reliable laboratory results that
are leading to good case management of malaria.
Together with a checklist, DTS were used to assess
the competency of health professionals in performing
RDTs, and in interpreting and reporting results. Profi-
ciency testing administration provided an opportunity
to identify and correct errors in reading faint positive
test lines. While the possibility of sample decay at week
24 is a possible reason for the reading error, the fact
that other technicians were able to correctly score that
test result for that sample suggests the technician ra-
ther than band intensity as the reason for the error.
Having DTS with parasite densities closer to the detec-
tion limit of the RDT may provide an opportunity to
teach health workers test interpretation, especially
where most problems with RDT test interpretationTable 4 Proficiency testing checklist performed during superv
Step Assessing questions Technician’s perfo
Proficiency testing
ARRL Wan
1 Correct volume of blood collected Yes No
2 Correct amount of blood applied Yes No
3 Blood applied to sample well Yes Yes
4 Correct amount of buffer dispensed Yes Yes
5 Buffer dispensed to buffer well Yes Yes
6 Timer set for incubation Yes Yes
7 Correct time set for incubation Yes Yes
8 Results read at time specified by test Yes Yes
9 Results interpreted correctly Yes Yes
Wan =Wanji Health Centre, Wal =Walanchiti Health Centre.exist. The use of DTS might improve overall testing
quality in the process.
In this study it is shown that well-characterized DTS
stored either at facility level ambient temperature condi-
tions or in a reference laboratory under refrigeration can
be used for RDT QC and proficiency-testing in a field-
implementable manner in Ethiopia and that the DTS are
stable under such conditions for a period of at least seven
months. These data complement and confirm reported
controlled laboratory-based experiments in which DTS
stored in a refrigerator remained stable for > two years
(Additional file 1). This study did not provide any RDT
testing data (except for universally negative results) that
would be relevant to the detection of P. vivax infections in
Ethiopia, since the DTS were prepared using P. falcip-
arum only.
DTS has several benefits over current methodologies for
RDT QC. First, observation of how tests are performed onisory visits showing sample result from the study sites
rmance
Week 12 Proficiency testing Week 24
. HC Wal. HC ARRL Wan. HC Wal. HC
Yes Yes Yes Yes
Yes Yes Yes Yes
Yes Yes Yes Yes
Yes Yes Yes Yes
Yes Yes Yes Yes
Yes Yes Yes Yes
Yes Yes Yes Yes
Yes Yes Yes Yes
Yes No Yes No
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present during the observation. However, in a country
such as Ethiopia with relatively low malaria prevalence,
such a situation is not guaranteed unless one spends a sig-
nificant amount of time at the facility. Even when a case is
available, the testing by a technician can be observed but
without the benefit of expected reactivity of the sample,
the quality of the test cannot be determined. Second, by
having DTS with known reactivity, it is possible to
monitor whether site-specific storage and transporta-
tion conditions could have compromised test perform-
ance. In addition, DTS can be used to adjust the density
of infection in samples and therefore the degree of diffi-
culty in interpreting results within a proficiency-testing
programme.
Conclusions
The ability of health workers to properly perform malaria
RDTs (proficiency testing) and to monitor the quality of
RDT test results can be assessed with cultured P. falcip-
arum DTS as an RDT testing substrate in rural areas of
Ethiopia. The DTS methodology can enhance the scale-up
of quality RDT testing. Evaluation of DTS developed with
well-characterized patient blood could also be explored in
order to make the method widely available.
Additional file
Additional file 1: Long-term testing of DTS stored at 4°C showing
reactivity up to 109 weeks of storage. Relative intensities of the
control “C” and the parasite specific “Pf” bands are indicated by “+” with
the number of “+”s denoting increasing band intensity.
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